MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway

References

• Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96–108.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.
   Google Scholar
• Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69:300–310.
   PubMed Web of Science ®Google Scholar
• Yan H, Xie H, Ying Y, et al. Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis. Cancer Manag Res. 2018;10:1627–1638.
   PubMed Web of Science ®Google Scholar
• Yan H, Ying Y, Xie H, et al. Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis. Cancer Manag Res. 2018;10:3781–3791.
   PubMed Web of Science ®Google Scholar
• Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388:2796–2810.
   PubMed Web of Science ®Google Scholar
• McConkey DJ, Choi W, Ochoa A, et al. Intrinsic subtypes and bladder cancer metastasis. Asian J Urol. 2016;3:260–267.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
   PubMed Web of Science ®Google Scholar
• Hu Z, Lin Y, Chen H, et al. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. Biochem Biophys Res Commun. 2013;435:82–87.
   PubMed Web of Science ®Google Scholar
• Li S, Xu X, Xu X, et al. MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochem Biophys Res Commun. 2013;441:976–981.
   PubMed Web of Science ®Google Scholar
• Liang Z, Li S, Xu X, et al. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1. Mol Cells. 2015;38:130–137.
   PubMed Web of Science ®Google Scholar
• Lin Y, Chen H, Hu Z, et al. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. FEBS Lett. 2013;587:2467–2473.
   PubMed Web of Science ®Google Scholar
• Wang X, Liang Z, Xu X, et al. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer. Cell Death Dis. 2016;7:e2503.
   PubMed Web of Science ®Google Scholar
• Wang X, Wu J, Lin Y, et al. MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6. J Exp Clin Cancer Res. 2014;33:69.
   PubMed Web of Science ®Google Scholar
• Xu X, Li S, Lin Y, et al. MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. J Transl Med. 2013;11:276.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhu Y, Liang Z, et al. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3beta/Snail signaling. Cell Death Dis. 2016;7:e2088.
   PubMed Web of Science ®Google Scholar
• Li J, Xu X, Meng S, et al. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer. Cell Death Dis. 2017;8:e3010.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen H, Lin Y, et al. MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cells. 2013;36:62–68.
   PubMed Web of Science ®Google Scholar
• Benetatos L, Hatzimichael E, Londin E, et al. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci. 2013;70:795–814.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang W, Jiang K, et al. MicroRNA-300 regulates the ubiquitination of PTEN through the CRL4B(DCAF13) E3 ligase in osteosarcoma cells. Mol Ther Nucleic Acids. 2018;10:254–268.
   PubMedGoogle Scholar
• Zhang JQ, Chen S, Gu JN, et al. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. J Cell Biochem. 2018;119:1027–1040.
   Google Scholar
• Zhang Y, Guo Y, Yang C, et al. MicroRNA-300 targets hypoxia inducible factor-3 alpha to inhibit tumorigenesis of human non-small cell lung cancer. Neoplasma. 2017;64:554–562.
   PubMed Web of Science ®Google Scholar
• Zhou F, Li Y, Hao Z, et al. MicroRNA-300 inhibited glioblastoma progression through ROCK1. Oncotarget. 2016;7:36529–36538.
   PubMedGoogle Scholar
• Lin CC, Chen PC, Lein MY, et al. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells. Oncotarget. 2016;7:9993–10005.
   PubMedGoogle Scholar
• Jin H, Xie Q, Guo X, et al. p63alpha protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion. J Biol Chem. 2017;292:15952–15963.
   PubMed Web of Science ®Google Scholar
• Luo KW, Wei C, Lung WY, et al. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-kappaB and MMP-9. J Nutr Biochem. 2017;41:56–64.
   PubMed Web of Science ®Google Scholar
• Gao Y, Guan Z, Chen J, et al. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9. Int J Oncol. 2015;47:690–700.
   PubMed Web of Science ®Google Scholar
• Lee JS, Leem SH, Lee SY, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol. 2010;28:2660–2667.
   PubMed Web of Science ®Google Scholar
• Ho HY, Lin CW, Chien MH, et al. Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma. J Pineal Res. 2016;61:479–492.
   PubMed Web of Science ®Google Scholar
• Wang W, Yang C, Wang XY, et al. MicroRNA-129 and −335 promote diabetic wound healing by inhibiting Sp1-Mediated MMP-9 expression. Diabetes. 2018;67:1627–1638.
   Google Scholar
• Lin H-Y, Chen Y-S, Wang K, et al. Fisetin inhibits epidermal growth factor–induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression. Mol Vis. 2017;23:900–910.
   PubMed Web of Science ®Google Scholar
• Khan A, Fornes O, Stigliani A, et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2018;46:D1284.
   PubMed Web of Science ®Google Scholar
• He J, Feng X, Hua J, et al. miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells. Cell Cycle. 2017;16:1943–1953.
   PubMed Web of Science ®Google Scholar
• Ge W, Han C, Wang J, et al. MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1. Am J Transl Res. 2016;8:3903–3911.
   PubMed Web of Science ®Google Scholar
• Haga CL, Phinney DG. MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem. 2012;287:42695–42707.
   PubMed Web of Science ®Google Scholar
• Lehner B, Kunz P, Saehr H, et al. Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone. BMC Cancer. 2014;14:495.
   PubMed Web of Science ®Google Scholar
• Li J, Ying Y, Xie H, et al. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer. FASEB J. 2018;fj201800667R.
   PubMed Web of Science ®Google Scholar
• Daizumoto K, Yoshimaru T, Matsushita Y, et al. A DDX31/Mutant-p53/EGFR axis promotes multistep progression of muscle-invasive bladder cancer. Cancer Res. 2018;78:2233–2247.
   PubMed Web of Science ®Google Scholar
• Devanand P, Kim SI, Choi YW, et al. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1. FEBS J. 2014;281:5581–5601.
   PubMed Web of Science ®Google Scholar
• Shin SS, Park SS, Hwang B, et al. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways. Oncol Rep. 2016;36:2313–2320.
   PubMed Web of Science ®Google Scholar